-
17 December 2020
Data saves lives. To end HIV, we must improve key population data collection now.
By Jinkou (Button) Zhao, Senior Specialist, Monitoring & Evaluation
Forty years after the beginning of the AIDS epidemic, the world is still struggling to collect quality data on the people who are the most affected by HIV, impeding the progress towards the eradication of the disease. -
10 December 2020
Put Human Rights at the Centre of our Battle Against COVID-19
By Peter Sands and Antonio Zappulla
Throughout history, people have faced pandemics: the bubonic plague, smallpox, influenza, HIV and now COVID-19. Pandemics affect people of every creed, color and class. But they do not affect everyone equally. -
02 December 2020
How the lessons the world learned in the fight against HIV can help us defeat COVID-19
By Peter Sands, Executive Director
World AIDS Day reminds us that while we battle to contain COVID-19, we still haven’t finished the fight against the last big pandemic to hit humanity. After four decades and the loss of over 32 million lives, the battle against HIV is still unwon. -
01 December 2020
Without Equity, We Cannot End COVID-19, HIV Or Any Other Pandemic
By Peter Sands and Mark Vermeulen
While COVID-19 continues to accelerate around the world, the last few weeks have seen new optimism in the fight against the pandemic. Pfizer and Moderna have shared data showing their vaccines are more than 90% effective. People now dare to dream tha... -
19 November 2020
COVID-19 must transform the definition of global health security
By Peter Sands, Executive Director
The recent announcements that multiple new coronavirus vaccines are showing strong results provide hope that life will eventually return to normal and the catastrophic death toll will end – good news we all desperately need right now. -
19 November 2020
Why drug-resistant tuberculosis poses a major risk to global health security
By Dr. Eliud Wandwalo, Head of Tuberculosis Department
Drug-resistant tuberculosis (DR-TB) is a form of antimicrobial resistance that is difficult and costly to treat. It is caused by TB bacteria that are resistant to at least one of the first-line existing TB medications, resulting in fewer treatment op...